Angiogenesis, endothelial cell functions, and tumor cell growth in biodegradable and nonbiodegradable devices.
Development of tissue engineering creates multiple potentials for clinical treatment and scientific research. Biodegradable collagen matrices have been found to support simultaneous autotransplantation of hepatocytes after major liver resection. Dynamic angiogenesis in biodegradable devices (BDD) and nondegradable devices (NDD) transplanted into the renal subcapsule and subcutaneous tissue was measured by the distribution of radiolabeled red blood cells and serum albumin. The circulation, microvascular integrity, and capacities of endothelial cells (adhesion, proliferation, and migration) were investigated within 2 weeks after subcutaneous transplantation of both devices. Patterns of tumor cell growth in both devices were morphologically studied. After subcutaneous transplantation, significant angiogenesis was noted at 1 week in BDD implants and from 2 weeks and on in NDD implants, with an increase in implant blood and plasma volumes. Leakage index of radiolabeled albumin in NDD implants was significantly higher than in BDD implants, while the leakage index 2 weeks after BDD implant was similar to that in subcutaneous tissues. Adhesion, proliferation and migration rates of endothelial cells isolated from both devices were higher than from subcutaneous tissues. Endothelial proliferation and migration rates in BDD implants were significantly higher at 1 week, while in NDD at 2 weeks. Tumor cells migrated and grew on the top surface of NDD with a flattened shape, while growing within the BDD forming a round mass. Endothelial capacities, angiogenetic procedure, and biological and physical characteristics of the device contribute to patterns of tumor cell growth in the device. Biodegradable collagen matrix with three-dimensional structure is suitable for simultaneous transplantation with cells without prevascularization.
Department of Surgery, Lund University Hospital, Lund, Sweden.
Xia
X
Zhao
Suzanne
S
Kalliomäki
Xiangdong
X
Wang
Jacob
J
Kalliomäki
Roland
R
Andersson
D020341:Absorbable Implants; D000230:Adenocarcinoma / Q000098:blood supply* / Q000473:pathology; D000818:Animals; D001672:Biocompatible Materials; D049109:Cell Proliferation; D003110:Colonic Neoplasms / Q000098:blood supply* / Q000473:pathology; D042783:Endothelial Cells / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D014407:Tumor Cells, Cultured
D001672:Biocompatible Materials